Bad Blood

(Axel Boer) #1

However, Theranos continued to minimize: Email with the subject line “Statement
by Theranos on CMS Audit Results” sent by Theranos spokeswoman Brooke
Buchanan to journalists at 1:49 p.m. EST on January 27, 2016.


the lab had continued to run: John Carreyrou and Christopher Weaver, “Theranos
Ran Tests Despite Quality Problems,” Wall Street Journal, March 8, 2016.


Theranos couldn’t refute: Email with the subject line “statements from Theranos”
sent by Brooke Buchanan to John Carreyrou and Mike Siconolfi at 3:35 p.m.
EST March 7, 2016.


But Heather King continued: King sent CMS several letters in March and early
April 2016 demanding that the agency make redactions before releasing the
inspection report to the press.


As the tug-of-war: Noah Kulwin, “Theranos CEO Elizabeth Holmes Is Holding a
Hillary Fundraiser with Chelsea Clinton,” Recode, March 14, 2016.


The fund-raiser was later relocated: Ed Silverman, “Avoiding ‘Teapot Tempest,’
Clinton Campaign Distances Itself from Theranos,” STAT, March 21, 2016.


Heather King tried to prevent us: Letter from Heather King to Jason Conti, copying
John Carreyrou, Mike Siconolfi, and Gerard Baker, dated March 30, 2016.


We posted it on the Journal’s website: John Carreyrou and Christopher Weaver,
“Theranos Devices Often Failed Accuracy Requirements,” Wall Street
Journal, March 31, 2016.


The coup de grâce: Letter from CMS’s Karen Fuller to Sunil Dhawan, Elizabeth
Holmes, and Ramesh Balwani dated March 18, 2016.


When we reported news of: John Carreyrou and Christopher Weaver, “Regulators
Propose Banning Theranos Founder Elizabeth Holmes for at Least Two
Years,” Wall Street Journal, April 13, 2016.


She had to come out: Holmes’s interview with Maria Shriver aired on April 18,
2016, and can be viewed on YouTube.


In a complete about-face: The AACC put out a press release on April 18, 2016,
saying Holmes would present her technology at its sixty-eighth annual
meeting.


She broke up with him: John Carreyrou, “Theranos Executive Sunny Balwani to
Depart Amid Regulatory Probes,” Wall Street Journal, May 12, 2016.


A week later, we reported that: John Carreyrou, “Theranos Voids Two Years of
Edison Blood-Test Results,” Wall Street Journal, May 18, 2016.


On June 12, 2016, it terminated: Michael Siconolfi, Christopher Weaver, and John
Carreyrou, “Walgreen Terminates Partnership with Blood-Testing Firm
Theranos,” Wall Street Journal, June 13, 2016.

Free download pdf